The association between ACE (angiotensin-converting enzyme) gene insertion/deletion (I/D) polymorphism and mortality has been inconsistently observed in earlier studies in patients on maintenance hemodialysis. We hypothesized ...
The aim of this review is to present recommendations of the currently valid Hungarian practice guidelines regarding antihypertensive therapy of the elderly and very elderly with different cardiovascular risk profiles, ...
Today, hypertension is considered endemic throughout the world. The number of individuals with high blood pressure and the increasing risk, morbidity and mortality caused by hypertension despite modern therapy do not ...
Az elmúlt harminc év kutatásai igen sok eredményt hoztak az akut és krónikus veseelégtelenség patofiziológiájával, klinikumával és terápiájával kapcsolatban. Jóval többet tudunk az uraemiás toxinokról és azok jellegzetességeiről, ...
Experimental and clinical trials in the field of bone biology helped to clarify the role of receptors, which belong to the tumor necrosis factor family, such as osteoprotegerin and receptor activator of nuclear factor ...
A szerzők nagy létszámú hypertoniás beteg esetében vizsgálták az antihipertenzív kezelés hatását a vérnyomás-variabilitásra az otthoni vérnyomásmérésre alapozott "day-to-day" módszer segítségével. A négy hónapos megfigyelési ...
Background: Resistance to erythropoiesis-stimulating agents
(ESAs) has been observed in patients with chronic kidney disease
(CKD) and it is associated with clinical outcomes. The presence
of ESA resistance cannot ...
Pulse pressure (PP) reflects increased large artery stiffness, which is caused, in part, by arterial calcification in patients with chronic kidney disease. PP has been shown to predict both cardiovascular and cerebrovascular ...
BACKGROUND: Osteoprotegerin (OPG) is a marker and regulator of
arterial calcification, and it is related to cardiovascular
survival in haemodialysis patients. The link between OPG and
aortic stiffening--a consequence ...
Skin autofluorescence (SAF) is a proven prognostic factor of mortality in hemodialysis patients. Traditional and nontraditional risk factors are almost equivalent in peritoneal dialysis (PD), and cardiovascular disease ...